Gensight Biologics (France) Market Value
| SIGHT Stock | EUR 0.37 0.05 15.62% |
| Symbol | Gensight |
Gensight Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gensight Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gensight Biologics.
| 11/02/2024 |
| 12/02/2024 |
If you would invest 0.00 in Gensight Biologics on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding Gensight Biologics SA or generate 0.0% return on investment in Gensight Biologics over 30 days. Gensight Biologics is related to or competes with Biophytis, Biosynex, and Eurobio Scientific. GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercializ... More
Gensight Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gensight Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gensight Biologics SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 18.83 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 8.57 |
Gensight Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gensight Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gensight Biologics' standard deviation. In reality, there are many statistical measures that can use Gensight Biologics historical prices to predict the future Gensight Biologics' volatility.| Risk Adjusted Performance | 0.0067 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | 1.49 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gensight Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Gensight Biologics Backtested Returns
Currently, Gensight Biologics SA is out of control. Gensight Biologics holds Efficiency (Sharpe) Ratio of 0.014, which attests that the entity had a 0.014% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Gensight Biologics, which you can use to evaluate the volatility of the firm. Please check out Gensight Biologics' Risk Adjusted Performance of 0.0067, standard deviation of 4.72, and Market Risk Adjusted Performance of 1.5 to validate if the risk estimate we provide is consistent with the expected return of 0.0662%. Gensight Biologics has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.0138, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Gensight Biologics are expected to decrease at a much lower rate. During the bear market, Gensight Biologics is likely to outperform the market. Gensight Biologics right now retains a risk of 4.71%. Please check out Gensight Biologics treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Gensight Biologics will be following its current trending patterns.
Auto-correlation | 0.19 |
Very weak predictability
Gensight Biologics SA has very weak predictability. Overlapping area represents the amount of predictability between Gensight Biologics time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gensight Biologics price movement. The serial correlation of 0.19 indicates that over 19.0% of current Gensight Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Gensight Biologics lagged returns against current returns
Autocorrelation, which is Gensight Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gensight Biologics' stock expected returns. We can calculate the autocorrelation of Gensight Biologics returns to help us make a trade decision. For example, suppose you find that Gensight Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Gensight Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gensight Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gensight Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gensight Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
Gensight Biologics Lagged Returns
When evaluating Gensight Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gensight Biologics stock have on its future price. Gensight Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gensight Biologics autocorrelation shows the relationship between Gensight Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in Gensight Biologics SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gensight Stock Analysis
When running Gensight Biologics' price analysis, check to measure Gensight Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gensight Biologics is operating at the current time. Most of Gensight Biologics' value examination focuses on studying past and present price action to predict the probability of Gensight Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gensight Biologics' price. Additionally, you may evaluate how the addition of Gensight Biologics to your portfolios can decrease your overall portfolio volatility.